GlassScriptPhysician profile
Elizabeth A Blakemore
NPI 1558475574
$4,066.64
in general payments reported to CMS, 2019-2025
12 companies · $493 in 2025
The $493 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $749 · 2020: $406 · 2021: $1,001 · 2022: $619 · 2023: $324 · 2024: $475 · 2025: $493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,291.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $1,914.86 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Allergan, INC. | $549.48 | 2019-2022 | |
| Sientra, INC. | $512.67 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $451.55 | 2019-2022 | |
| Abbvie INC. | $263.63 | 2023-2025 | Botox, Natrelle Saline-Filled Breast Implants |
| Galderma Laboratories, L.P. | $184.34 | 2019-2025 | Dysport |
| Dilon Technologies, INC. | $46.19 | 2025 | Hemoblast Bellows |
| Misonix INC | $46.12 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $39.49 | 2022-2023 | Exparel, Zilretta, Iovera |
| Axogen | $23.23 | 2025 | |
| Avanos Medical | $20.41 | 2021 | |
| Baxter Healthcare | $14.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Blakemore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.